Clinical Trials on Nasolacrimal Tract Obstruction

Total 107271 results

University of Minnesota

Recruiting

To Investigate Airway Oxygen Concentrations During Rigid Bronchoscopy Procedures Performed With High Frequency Jet Ventilation

Central Airway Obstruction

United States
AstraZeneca
Parexel

Completed

A Study to Assess Drug Absorption of Fixed Dose Combinations of Budesonide, Glycopyrronium, and Formoterol

Chronic Obstructive Pulmonary Disease (COPD)

United States
Chiesi Farmaceutici S.p.A.

Completed

2-arm Parallel Group Study of Fixed Combination of CHF 5993 vs Ultibro® in COPD Patients (TRIBUTE)

Chronic Obstructive Pulmonary Disease (COPD)

Italy
Chiesi Farmaceutici S.p.A.

Completed

Safety and Efficacy Study of Glyco pMDI After Single and Repeated Administration (GLY2)

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Pearl Therapeutics, Inc.

Completed

Study to Assess the Safety and Tolerability of PT010, PT009 and PT003 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

COPD

United States
Guangzhou Institute of Respiratory Disease

Completed

Quality Control for Chronic Obstructive Pulmonary Disease

COPD

China
Bayside Health
Newcastle University; Austin Health

Completed

Effect of Exercise Training on Salivary Immunoglobulin A in Patients With Chronic Obstructive Pulmonary Disease

COPD

Australia
Fisher and Paykel Healthcare
Medical Research Institute of New Zealand; Alana Healthcare

Terminated

Nasal High Flow Therapy 30 Day Readmission Study (N3ADS)

Chronic Obstructive Pulmonary Disease | COPD

United States, New Zealand
Chiesi Farmaceutici S.p.A.

Completed

Study to Evaluate Efficacy/Safety of 4 Doses of CHF5259 Via Dry Powder Inhaler (DPI) in Patients With COPD (GlycoNEXT)

Chronic Obstructive Pulmonary Disease (COPD)

Czechia, Germany, Hungary, Romania
Cardiff University
GlaxoSmithKline; Cardiff Metropolitan University

Completed

Assessment of Risk in Chronic Airways Disease Evaluation (ARCADE)

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
AstraZeneca

Completed

Phase IV O2 Consumption Study in COPD Patients.

Chronic Obstructive Pulmonary Disease (COPD)

United States
Sunovion Respiratory Development Inc.

Completed

A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (GOLDEN-2)

COPD

United States
Assiut University

Unknown

VSV Versus PSV as a Weaning Mode of Mechanically Ventilated Chronic Obstructive Pulmonary Disease Patients

COPD

Egypt
Radboud University Medical Center

Unknown

Exacerbation Self-management in COPD: The ACCESS Study (ACCESS)

Chronic Obstructive Pulmonary Disease (COPD)

Netherlands
Brigham and Women's Hospital
AstraZeneca

Terminated

Changes in Cardiac Function in COPD Patients After Administration of Budesonide/Formoterol (Symbicort®) Versus Placebo (AZCO)

Chronic Obstructive Pulmonary Disease (COPD)

United States
Pearl Therapeutics, Inc.

Completed

Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD (PINNACLE 2)

Chronic Obstructive Pulmonary Disease (COPD)

United States
University of Aarhus
Aarhus University Hospital

Completed

Magnesium is Associated With QoL in COPD: A Cross-sectional Study

Chronic Obstructive Pulmonary Disease (COPD)

Denmark
Universidad de Granada

Completed

Physiotherapy in Patients With Stable Chronic Obstructive Pulmonary Disease

COPD

Spain
Medical University of Warsaw

Unknown

Effects of Osteopathic Techniques on Residual Volume in Severe Chronic Obstructive Pulmonary Disease

COPD

Poland
University Hospital Southampton NHS Foundation...
GlaxoSmithKline

Completed

Microbiology & Immunology of the Chronically-inflamed Airway (MICA)

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Novartis Pharmaceuticals

Completed

A Multi-centre Randomized Double Blind 52-week Study to Assess the Safety of QVA149 Compared to QAB149 in Patients With COPD Who Have Moderate to Severe Airflow Limitation

Chronic Obstructive Pulmonary Disease (COPD)

United States, Romania, Hungary, Bulgaria, Spain, Finland, Puerto Rico
Novartis Pharmaceuticals

Completed

A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation.

Chronic Obstructive Pulmonary Disease (COPD)

United States, Poland, Romania, Canada, Philippines, Spain, Ukraine, Vietnam
Eisai Co., Ltd.

Completed

Effects of Lysozyme on Acute Exacerbation of Chronic Obstructive Pulmonary Disease : A Randomised Placebo-Controlled Study

COPD

Japan
Fundación Pública Andaluza Progreso y Salud

Completed

Roflumilast Safety Administered Once a Day on Alternate Days for Two Weeks Compared to the Usual Dosage Once Daily (ROFLU2011)

Chronic Obstructive Pulmonary Disease (COPD)

Spain
COPD Foundation
National Jewish Health

Completed

COPD Research Registry

Chronic Obstructive Pulmonary Disease (COPD)

United States
Lallemand Pharma AG
Sprim Advanced Life Sciences

Completed

Advanced Immunological Approach in COPD Exacerbation (AIACE)

Chronic Obstructive Pulmonary Disease (COPD)

Italy
Nicolaas J Smit PhD

Completed

A Six Month Randomized Controlled Clinical Trial of Lung Flute in Patients With Chronic Obstructive Pulmonary Disease

COPD

United States
Novartis Pharmaceuticals

Completed

12-week Open-label Evaluation of Efficacy and Safety of Indacaterol (MOVE-ON)

Chronic Obstructive Pulmonary Disease (COPD)

Israel
AstraZeneca

Completed

CorRELation Between PatIent PErception and Findings on Clinical Examination (RELIEF)

Chronic Obstructive Pulmonary Disease (COPD)

Romania
Medical University of Vienna

Unknown

Acetylic Salicylic Acid for the Treatment of Chronic Obstructive Pulmonary Disease (ASA-COPD)

COPD

Austria
Groningen Research Institute for Asthma and COPD

Completed

A Structured Lifestyle Intervention on Daily Physical Activity Level in COPD (COACH)

Chronic Obstructive Pulmonary Disease (COPD)

Netherlands
RWTH Aachen University

Completed

Electrical Impedance Tomography of Lung in Child and Young Age (EIT-Lunge)

Obstructive Lung Diseases

Germany
Danbury Hospital

Not yet recruiting

Curcumin in Management of Chronic Obstructive Pulmonary Disease

COPD

United States
Macquarie University, Australia

Completed

The Use of Aeriseal ® in the Management of Collateral Ventilation Positive COPD Patients Undergoing ELVR Utilizing Endobronchial Valves.

Chronic Obstructive Pulmonary Disease (COPD)

Australia
Mylan Inc.
Theravance Biopharma

Completed

TD-4208 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects

Chronic Obstructive Pulmonary Disease (COPD)

United States
Johns Hopkins University
National Institute of Environmental Health Sciences (NIEHS)

Completed

Clinical Trial of Air Cleaners to Improve Indoor Air Quality and COPD Health

Chronic Obstructive Pulmonary Disease (COPD)

United States
AstraZeneca

Completed

A Study to Evaluate the Effects of BGF and GFF on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPD

Chronic Obstructive Pulmonary Disease (COPD)

Netherlands, Belgium
Translational Research Center for Medical Innovation...
Kobe City Medical Center General Hospital

Completed

Study of Long-term HFNC for COPD Patients With HOT (FLOCOP)

Chronic Obstructive Pulmonary Disease (COPD)

Japan
Pearl Therapeutics, Inc.

Completed

Efficacy and Safety Study of Two Dose Levels of AZD2115 in Subjects With Moderate to Severe COPD

Chronic Obstructive Pulmonary Disease (COPD)

United States
Kaiser Permanente
Patient-Centered Outcomes Research Institute

Completed

Walk On! Physical Activity Coaching

Chronic Obstructive Pulmonary Disease (COPD)

United States
Fu Jen Catholic University

Completed

Hemodynamic Effects of Negative Pressure Ventilation in Chronic Obstructive Pulmonary Disease

COPD

Taiwan
Ottawa Hospital Research Institute

Completed

Feasibility and Safety of Immunoglobulin (Ig) Treatment in COPD Outpatients With Frequent Exacerbations: Pilot Study 1

Chronic Obstructive Pulmonary Disease (COPD)

Canada
AstraZeneca

Completed

Association of COPD Maintenance Medication Adherence With Resource Use and Cost Among COPD Patients (MARU)

Chronic Obstructive Pulmonary Disease (COPD)

China
Sheffield Teaching Hospitals NHS Foundation Trust
University of Sheffield; National Institute for Health Research: CLAHRC YH; The... and other collaborators

Completed

Use of the SMART COPD Physical Activity App in Pulmonary Rehabilitation

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Conde, Bebiana, M.D.
ResMed

Unknown

TELE-monitoring in Chronic Obstructive Pulmonary Disease (TELECOPD)

COPD

Portugal
Universidad de Granada

Unknown

Physiotherapy in Acute Exacerbation of Chronic Obstructive Pulmonary Disease

COPD

Spain
University of Aarhus
Eurostars

Unknown

Feasibility & Effect of a Tele-rehabilitation Program for Chronic Obstructive Pulmonary Disease vs. Standard Rehabilitation (TELEKOL-1)

COPD

Denmark
Loughborough University

Completed

Sedentary Behaviour, Physical Activity and Cardiometabolic Risk in Chronic Obstructive Pulmonary Disease (SPAaRC)

COPD

United Kingdom
Imperial College London

Completed

Effects of Long Term Antibiotic Therapy on Exacerbation Rate in Stable COPD Patients

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Hospital Clinic of Barcelona

Completed

Muscular Training-induced Changes in COPD

Healthy | Chronic Obstructive Pulmonary Disease

Clinical Trials on Nasolacrimal Tract Obstruction

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo, DR of

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations